Search

You searched for "neuroretinopathy"

524 results found

Report on ‘2024: Artificial Intelligence and the Eye’

3 June 2024 | | EYE - General
As the application of artificial intelligence (AI) is brought to the foray of clinical medicine, you can be forgiven for thinking that it is a relatively recent technology. However, researchers and computer scientists have been working on it for many...

Developments in retinal pigmentation measurement and the hopes of an equitable future

4 August 2025 | | EYE - Vitreo-Retinal, EYE - Imaging
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...

Quantum imaging research could improve retinal scans

28 October 2025 | OCT, Imaging, Diagnosis, research, Retina
New EU-funded feasibility project is testing a quantum approach that could reveal finer detail in the eye than ever before. A European research consortium is exploring a new quantum imaging technique that could one day help clinicians see the earliest...

Eyes on Rwanda: Lessons from an international ophthalmology experience

2 October 2025 | | EYE - Cataract, EYE - Glaucoma
On the 26 February 2025, I travelled to Rwanda on the invitation of a former Belfast trainee, Michael Mikhail. Michael is now one of only two vitreoretinal (VR) surgeons in Rwanda, a country with a population of 14 million. Born...

The world of the unseen

3 October 2024 | | EYE - Imaging, EYE - General
We are witnessing an incredible era of miraculous and marvellous discoveries. The globe has seen breakthroughs in science, medicine, creative arts, technology, digital media, and much more. In warm, sunny April, Emerald Network celebrated its 20th year of Eid events,...

Innovations in posterior uveitis: In conversation with Dr Colin Chu

1 July 2025 | | EYE - Imaging
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...

Lessons from an unusual case of syphilis

3 August 2023 | | EYE - Vitreo-Retinal
The rise of syphilis transmission rates over the past two decades has been one of public health’s great puzzles. In the UK, the situation has reached epidemic levels, with a 126% increase between 2013 and 2018 [1]. We present a...

The invisible touch: a VISION 2020 LINK with Indonesia

1 February 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Refractive, EYE - Pathology, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Indonesia’s population, the world’s fourth largest, is spread across 6,000 inhabited islands. Whilst some areas (e.g. Kalimantan, Papua) are relatively sparsely populated, Java is the world’s most densely populated island, with twice the population of the UK in half the...

IN FOCUS - The achievements and lasting effects of VISION 2020

1 April 2020 | | EYE - General
Blindness is a major public health problem globally. The first estimate of global blindness by the World Health Organization (WHO) in 1972 provided a figure of 10 to 15 million, which was considered an underestimate [1]. In 1999, an extraordinary...

Reflections on a twelve-year partnership: The Makassar-Dundee LINK

3 June 2021 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
In the first article of a two-part series (see Part 2 here), the authors provide an overview of this hugely successful partnership and how they overcame the challenges of COVID-19. What began in 2008 as a connection between equals, has...

More sensitive visual acuity test for age-related macular degeneration

1 October 2016 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...